Buprigesic Patch 5
Marketer
Neon Laboratories Ltd
Salt Composition
Buprenorphine (5mg)
Overview Buprigesic Patch 5
Buprenorphine/naloxone transdermal patches (5 mcg/hr) are indicated for managing moderate-to-severe pain and opioid dependence. They mitigate withdrawal symptoms associated with opioid cessation. Your physician will provide comprehensive application instructions; adhere strictly to these for optimal therapeutic effect. Dosage and treatment length are individualized based on your condition and response. Maintain consistent use and avoid abrupt discontinuation unless medically directed. Common adverse reactions include constipation, vertigo, somnolence, cephalalgia, and nausea. These effects may be more pronounced initially or with dosage adjustments; typically, they subside with continued use. Persistent or severe side effects warrant patch removal and immediate medical attention. Prior to initiating treatment, disclose any pre-existing conditions or concurrent medications to your doctor, as drug interactions are possible. This is particularly crucial for pregnant or lactating individuals who should seek medical counsel before commencement.
Uses of Buprigesic Patch 5
Morphine addiction; significant to intense pain.
Major Benefits of Buprigesic Patch 5:
Administer this medication according to your physician's prescribed dosage and schedule. Always verify the product information on the packaging prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective covering. Avoid contact with the adhesive surface. Apply the patch firmly to the skin, adhesive side down, ensuring even contact.
Common Side effects of Buprigesic Patch 5:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Buprigesic Patch 5:
Apply this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Always verify the product label prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Then, firmly affix the patch to the skin with the adhesive side down, ensuring even contact.
How Buprigesic Patch 5 works:
Buprigesic Patch 5, a partial opioid agonist, mitigates opioid withdrawal by mimicking the effects of opioid medications. Its analgesic action stems from its interaction with specific brain receptors, modifying the body's pain perception and response.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Buprigesic Patch 5 during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Buprigesic Patch 5 while breastfeeding is likely unsafe. Available human data indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingNone
No known drug interactions.
KidneyCAUTION
Patients with severe renal impairment should use Buprigesic Patch 5 cautiously. Dosage modification of Buprigesic Patch 5 might be necessary; physician consultation is recommended.
LiverCAUTION
Patients with significant liver dysfunction should use Buprigesic Patch 5 cautiously. Dosage modification of Buprigesic Patch 5 may be necessary. Physician consultation is advised. An alternative pain reliever offering greater dosing flexibility might be preferable for individuals with severely compromised liver function.
What if you forget to take Buprigesic Patch 5 :
NA
Facts to Know About Buprigesic Patch 5
| Label | Value |
|---|---|
| Chemical Classification | Phenanthrene Derivatives |
| Developing Habits | . |
| Treatment Category | Neuroscience Central Nervous System |

